TROP-2 PET/CT Scan for Colorectal Cancer Diagnosis
Part of Cancer clinical trials.
This study tests a new PET/CT scan that uses a special tracer (TROP-2) to take pictures of solid tumors, like colorectal cancer. The goal is to see if this scan can help doctors find and diagnose cancer more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have colorectal cancer that was confirmed by a biopsy or surgery.
- You are willing to follow all study procedures and sign a consent form.
- You do not have severe liver or kidney problems.
- You have not had targeted therapy before your PET/CT scan or radiation therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.
This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.
This trial tests a new type of PET scan that uses a special antibody to find a marker called Trop2 on many common solid tumors. It may help doctors see tumors more clearly without needing a biopsy.
This study uses a special PET/CT scan to better tell if a lung nodule is non-small cell lung cancer. If you have a solid nodule in your lung that's at least 8 mm and might be cancer, this scan could help get a clearer diagnosis.
This study uses a special PET scan with a tracer called 68Ga-NOTA-H006 to look for cancer in people with pancreatic, lung, or colorectal cancer. It may help doctors see the cancer more clearly.
This trial uses a special PET scan to see if a type of drug called Trop2-ADC is working in people with advanced breast cancer. The scan may help doctors decide if the treatment is right for you.
Hear when a new Positron Emission Tomography trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.